(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RXLIVE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

RXLIVE

ST13

US500000090393005

Class

44

Filing

90393005

Registration

6944080

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

01/03/2023

Trademark type

Combined

Nice classes

44

Filing date

12/18/2020

Registration date

01/03/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/03/2023

Last transaction

01/03/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

05/01/2021

First use in commerce

05/01/2021

Drawing code

3

Owner type

01

Owner location

St. Petersburg, FL

Examiner

HETZEL, DANNEAN

Law office

L60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording RXLIVE appearing in dark blue with the dot above the letter "I" in teal and the forward slash of the letter "X" in teal. To the top right of the wording is a cross created by four arrows. The top left arrow appears in pink, top right arrow in teal, bottom right arrow in orange, and bottom left arrow in purple.

Holders and representatives

Holders

M. E. (pessoa física)

Representatives

Mark Engelen

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Consulting services in the field of health

Publications

History of USPTO decisions and trademark events.

38 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/03/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

01/03/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/29/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/28/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

11/28/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/28/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

11/28/2022

SNEA

SU-EXAMINER'S AMENDMENT WRITTEN

11/28/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/10/2022

GNRT

NON-FINAL ACTION E-MAILED

05/10/2022

CNRT

SU - NON-FINAL ACTION - WRITTEN

05/10/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/04/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/04/2022

IUAF

USE AMENDMENT FILED

04/21/2022

EISU

TEAS STATEMENT OF USE RECEIVED

04/21/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/19/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/22/2022

PUBO

PUBLISHED FOR OPPOSITION

02/22/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/02/2022

ALIE

ASSIGNED TO LIE

01/19/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/19/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

01/19/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/19/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

01/19/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/19/2022

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

01/19/2022

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

01/18/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/02/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/02/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/02/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/02/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/15/2021

GNRT

NON-FINAL ACTION E-MAILED

06/15/2021

CNRT

NON-FINAL ACTION WRITTEN

06/15/2021

DOCK

ASSIGNED TO EXAMINER

06/14/2021

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

03/02/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/01/2021

NWAP

NEW APPLICATION ENTERED

12/22/2020

Continuous trademark protection

Get notified about every new filing that threatens RXLIVE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.